Recombinant HLA-DRA 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant HLA-DRA 抗体 (ABIN7828289)
抗原
See all HLA-DRA 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Recombinant HLA-DRA Monoclonal Antibody
-
纯化方法
- Protein A purified
-
免疫原
- Recombinant human HLA-DRA fragment
-
亚型
- IgG, kappa
-
-
-
-
应用备注
- IHC 1:50-1:100,FCM 1:50
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
-
有效期
- 12 months
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
别名
- HLA-DRA
-
背景
- HLA-DRA,HLA-DRA1,major histocompatibility complex,class II,DR alpha,DR alpha chain,DR alpha chain precursor,DRA,DRB1,DRB4,Histocompatibility antigen HLA DR alpha,HLA class II histocompatibility antigen,HLA class II histocompatibility antigen DR alpha chain,HLA DR1B,HLA DR3B,HLA DRA,HLA DRA1,HLA DRB1,HLA DRB3,HLA DRB4,HLA DRB5,HLADR4B,HLADRA1,HLADRB,Major histocompatibility complex class II DR alpha,Major histocompatibility complex class II DR beta 1,Major histocompatibility complex class II DR beta 3,Major histocompatibility complex class II DR beta 4,Major histocompatibility complex class II DR beta 5,MGC117330,MHC cell surface glycoprotein,MHC class II antigen DRA,MHC II,MLRW,An alpha chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the beta chain HLA-DRB, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DR-restricted CD4-positive T cells. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [
-
UniProt
- P01903
-
途径
- TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
抗原
-